FdaApplication
NDA 020303
Identifiers
- fda_app_no: NDA020303
Properties
| Property | Value |
|---|---|
| applicant_name | WYETH PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 1994-12-30 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PREMPHASE (PREMARIN;CYCRIN 14/14) | ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE | 0.625MG,0.625MG;N/A,5MG | TABLET;ORAL-28 |
| PREMPRO (PREMARIN;CYCRIN) | ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE | 0.625MG,0.625MG;2.5MG,2.5MG | TABLET;ORAL-28 |
2 products